Results 131 to 140 of about 89,998 (263)

Correction: Unmasking the hidden risk: potential implication of pullback pressure gradient in ischemia-negative lesions. [PDF]

Cardiovasc Interv Ther
Ando H, Collet C, Sakai K, Ohashi H, Amano T.   +4 more
europepmc   +1 more source

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source

Artificial Intelligence-driven Detection, Mapping, and Personalized Therapy for Atrial Fibrillation. [PDF]

J Innov Card Rhythm Manag
Gonzalez DJ, Kambampati S, Godinez E, Paranjpe I, Chatterjee K, Devathu R, Verma A, Sun E, Ma C, Fazal M, Baykaner T.   +10 more
europepmc   +1 more source

Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction This final analysis of a multicenter, prospective postmarketing surveillance study evaluated the safety of daprodustat in patients with chronic kidney disease anemia in routine clinical practice in Japan. Methods Patients who initiated daprodustat between September 2020 and July 2022 were registered.
Tadao Akizawa, Kyomi Kanaya, Kiyomi Aizawa, Masanori Onoki, Hirofumi Ozeki, Kazuko Suzuki, Ai Hayashi, Tomohiko Asamura   +7 more
wiley   +1 more source

You Can't Launch This: Trust as Infrastructure in Digital Behavioral Health. [PDF]

J Med Internet Res
van Mierlo T.
europepmc   +1 more source

Forecasting the Dialysis Burden in Japan: Validation‐Based Projections of Prevalence and Incidence Through 2050

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin, Berrak Itır Aylı, Nüket Paksoy   +2 more
wiley   +1 more source

Low-Grade Appendiceal Mucinous Neoplasm (LAMN) Presenting Acutely: A Case Report and Concise Review of Surgical Decision-Making. [PDF]

Int Med Case Rep J
Eghbali M, Gohari M, Mohebbi R.
europepmc   +1 more source

Association Between Individualized Education for Kidney Replacement Therapy Modality Selection and Peritoneal Dialysis Initiation: A Cross‐Sectional Study

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Peritoneal dialysis (PD) is an established home‐based kidney replacement therapy (KRT), but its uptake remains low in Japan. We evaluated whether individualized education in a dedicated outpatient clinic was associated with the initiation of PD.
Yasuko Ito, Ryuichi Yoshimura, Takaki Yamauchi, Yuta Funakoshi, Hirotaka Sonoda, Seiji Kobayashi, Hiroyuki Terawaki, Takafumi Ito   +7 more
wiley   +1 more source

Governing Ethical Tensions in Youth Digital Mental Health Research. [PDF]

JMIR Ment Health
Ørjasæter KB, Rennick-Egglestone S, Børresen KØ, Moe CF, Leiler A, Sigurdardóttir HD, Colado VMP, Vogelsang M, Nambazira T, Trovåg J, Valderaune V, Skjesol I, Ng F, Ness O, Slade M.   +14 more
europepmc   +1 more source

Organoids in pediatric cancer research

FEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source